. . . . . . . . . . . . . . . . . . . . . "2007-04-01T00:00:00Z"^^ . "clinical trial"@en-gb . . . . "26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)"@nl . "26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)"@en . . "26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)"@en . . . . . . . . . "ensayo cl\u00EDnico"@es . . "40"^^ . "clinical trial"@en . . . . . . "assaig cl\u00EDnic"@ca . "2059"^^ . "klinisch onderzoek"@nl . . . "NCT00463567" . "26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)"@en . . "clinical trial"@en-us . . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . "A 26-week Treatment, Multicenter, Randomized, Double Blind, Double Dummy, Placebo-controlled, Adaptive, Seamless, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Two Doses of Indacaterol (Selected From 75, 150, 300 & 600 \u00B5g o.d.) in Patients With Chronic Obstructive Pulmonary Disease Using Blinded Formoterol (12 \u00B5g b.i.d.) and Open Label Tiotropium (18 \u00B5g o.d.) as Active Controls"@en . . . . . . . . . . . "clinical trial"@en-ca . . . . . . "26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)"@nl . "26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)"@nl . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . "ensaio cl\u00EDnico"@gl . . . . . "2008-08-01T00:00:00Z"^^ . . . . . . . . . . . . . . . . "essai clinique"@fr . . .